{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T13:30:46Z","timestamp":1794922246325,"version":"4.9.1"},"reference-count":115,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1828,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1533-2500.2010.00378.x","type":"journal-article","created":{"date-parts":[[2010,5,17]],"date-time":"2010-05-17T08:03:37Z","timestamp":1274083417000},"page":"428-450","source":"Crossref","is-referenced-by-count":235,"title":["Current Knowledge of Buprenorphine and Its Unique Pharmacological Profile"],"prefix":"10.1111","volume":"10","author":[{"given":"Joseph","family":"Pergolizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Aloisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Dahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg","family":"Filitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Langford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Likar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Mercadante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Morlion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Raffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Sabatowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi A.","family":"Weinbroum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,8,30]]},"reference":[{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejpain.2008.04.011","article-title":"Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine","volume":"13","author":"Kress","year":"2008","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1163\/156856903321579334","article-title":"Efficacy and tolerability of a new opioid analgesic formulation, buprenorphine transdermal therapeutic system (TDS), in the treatment of patients with chronic pain. A randomised, double-blind, placebo-controlled study","volume":"15","author":"B\u00f6hme","year":"2003","journal-title":"Pain Clin"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","article-title":"Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"25","author":"Sittl","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB4|cit4","first-page":"15","article-title":"Buprenorphine TDS: the clinical development-rationale and results","volume":"133","author":"Radbruch","year":"2003","journal-title":"Int J Clin Pract Suppl"},{"issue":"1","key":"10.1111\/j.1533-2500.2010.00378.x-BIB5|cit5","first-page":"13","article-title":"Efficacy and tolerability of buprenorphine TDS in cancer pain patients","volume":"10","author":"Radbruch","year":"2003","journal-title":"Eur J Palliat Care"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","article-title":"Transdermal buprenorphine in the treatment of chronic pain: results of a Phase III, multi-center, randomised, double-blind, placebo-controlled study","volume":"26","author":"Sorg","year":"2004","journal-title":"Clin Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.clinthera.2006.06.012","article-title":"Long-term management of chronic pain with transdermal buprenorphine: a multi-center, open-label, follow-up study in patients from three short-term clinical trials","volume":"28","author":"Likar","year":"2006","journal-title":"Clin Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpainsymman.2007.09.011","article-title":"Efficacy and safety of transdermal buprenorphine: a randomized, placebo-controlled trial in 289 patients with severe cancer pain","volume":"36","author":"Poulain","year":"2008","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/030079905X53315","article-title":"Transdermal buprenorphine in clinical practice-a post-marketing surveillance study in 13,179 patients","volume":"21","author":"Griessinger","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.acpain.2007.07.002","article-title":"Examination of the preclinical antinociceptive efficacy of buprenorphine and its designation as full- or partial-agonist","volume":"9","author":"Raffa","year":"2007","journal-title":"Acute Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0022-3565(24)29586-0","article-title":"Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist","volume":"297","author":"Huang","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3727\/000000004783992927","article-title":"G-protein coupling and efficacy of mu-opioid agonists: relationship to behavioral efficacy","volume":"8","author":"Traynor","year":"2004","journal-title":"Rev Analg"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2004.11.052","article-title":"Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain","volume":"507","author":"Christoph","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1038\/sj.npp.1300251","article-title":"Effects of buprenorphine maintenance dose on \u03bc-opioid receptor availability, plasma concentrations, and antagonist blockade in heroin-dependent volunteers","volume":"28","author":"Greenwald","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB15|cit15","volume-title":"Netter's Illustrated Pharmacology","author":"Raffa","year":"2005"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1476-5381.2009.00209.x","article-title":"Identification of an additional supraspinal component to the analgesic mechanism of action of buprenorphine","volume":"157","author":"Ding","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB17|cit17","first-page":"295","article-title":"The abdominal constriction response and its suppression by analgesic drugs in the mouse","volume":"32","author":"Collier","year":"1968","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB18|cit18","first-page":"502","article-title":"The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawal reflex in rats","volume":"13","author":"Janssen","year":"1963","journal-title":"Arzneimittelforschung"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200105000-00021","article-title":"Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice","volume":"94","author":"Dahan","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/bja\/ael051","article-title":"Buprenorphine induces ceiling in respiratory depression but not in analgesia","volume":"96","author":"Dahan","year":"2006","journal-title":"Br J Anaesth"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1152\/jn.1991.66.1.190","article-title":"Neurogenic hyperalgesia psychophysical studies of underlying mechanisms","volume":"66","author":"LaMotte","year":"1991","journal-title":"J Neurophysiol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000542-200108000-00022","article-title":"A new model of electrically evoked pain and hyperalgesia in human skin","volume":"95","author":"Koppert","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/00000542-200203000-00032","article-title":"A qualitative and quantitative systematic review of preemptive analgesia for postoperative pain relief","volume":"96","author":"Moiniche","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine","volume":"92","author":"Celerier","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pain.2005.06.030","article-title":"Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model","volume":"118","author":"Koppert","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/brain\/123.3.560","article-title":"Encoding of burning pain from capsaicin-treated human skin in two categories of unmyelinated nerve fibres","volume":"123","author":"Schmelz","year":"2000","journal-title":"Brain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB27|cit27","first-page":"72","article-title":"Quantifizierung analgetischer und antihyperalgetischer Effekte von Buprenorphin und Fentanyl am Menschen","volume":"18","author":"Tr\u00f6ster","year":"2004","journal-title":"Schmerz"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(03)00294-X","article-title":"Naloxone provokes similar pain facilitation as observed after short-term infusion of remifentanil in humans","volume":"106","author":"Koppert","year":"2003","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0014-2999(91)90485-9","article-title":"Buprenorphine and morphine cause antinociception by different tranduction mechanisms","volume":"195","author":"Wheeler-Aceto","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/j.1476-5381.1995.tb13346.x","article-title":"Subgroups among \u03bc-opioid receptor agonists distinguished by ATP-sensitive KC channel-acting drugs","volume":"114","author":"Ocana","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB31|cit31","first-page":"97","volume-title":"Opioid Sensitivity of Chronic Non-cancer Pain","author":"Gourlay","year":"1998"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderrah","year":"2000","journal-title":"J Neurosci"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.pain.2006.07.003","article-title":"Tramadol, fentanyl and sufentanil but not morphine block voltage-operated sodium channels","volume":"126","author":"Haeseler","year":"2006","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1191\/0269216306pm1126oa","article-title":"Opioid-induced respiratory effects: new data on buprenorphine","volume":"20","author":"Dahan","year":"2006","journal-title":"Palliat Med"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/bja\/64.3.276","article-title":"Buprenorphine disposition in patients with renal impairment: single and continuous dosing, with special reference to metabolites","volume":"64","author":"Hand","year":"1990","journal-title":"Br J Anaesth"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejpain.2005.12.001","article-title":"Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine","volume":"10","author":"Filitz","year":"2006","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/syn.890210109","article-title":"Ligand selectivity of cloned human and rat opioid mu receptors","volume":"21","author":"Rothman","year":"1995","journal-title":"Synapse"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/bja\/aei145","article-title":"Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats","volume":"94","author":"Dahan","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11095-007-9440-z","article-title":"Pharmacokinetic-pharmacodynamic modeling of the effectiveness and safety of buprenorphine and fentanyl in rats","volume":"25","author":"Yassen","year":"2008","journal-title":"Pharm Res"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200607000-00012","article-title":"Naloxone reversal of buprenorphine-induced respiratory depression","volume":"105","author":"Van Dorp","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF02446868","article-title":"Wet wedge spirometer for the accurate continuous measurement of ventilation under anaesthesia","volume":"23","author":"O'Connor","year":"1985","journal-title":"Med Biol Eng Comput"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0165-5728(97)00216-6","article-title":"Opiates and infections","volume":"83","author":"Risdahl","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/SPC.0b013e3282f5272e","article-title":"Opioid-induced immunosuppression","volume":"2","author":"Sacerdote","year":"2008","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.1074\/jbc.M604367200","article-title":"Transcriptional and epigenetic regulation of interleukin-2 gene in activated T cells by morphine","volume":"282","author":"Wang","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1189\/jlb.0406237","article-title":"Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes","volume":"81","author":"Martucci","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.1074\/jbc.M301224200","article-title":"Morphine negatively regulates interferon-gamma promoter activity in activated murine T cells through two distinct cyclic AMP dependent pathways","volume":"278","author":"Wang","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.mjt.0000132250.95650.85","article-title":"Opioid therapy and immunosuppression","volume":"11","author":"Vallejo","year":"2004","journal-title":"Am J Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1191\/0269216306pm1124oa","article-title":"Opioids and the immune system","volume":"20","author":"Sacerdote","year":"2006","journal-title":"Palliat Med"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1189\/jlb.72.1.43","article-title":"Differential tolerance development in the modulation of macrophage cytokine production in mice","volume":"72","author":"Limiroli","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbi.2005.02.002","article-title":"Multiple opioid receptors on immune cells modulate intracellular signalling","volume":"20","author":"Sharp","year":"2006","journal-title":"Brain Behav Immun"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1189\/jlb.71.5.782","article-title":"The immunosuppressive effects of chronic morphine treatment are partially dependent on corticosterone and mediated by the mu-opioid receptor","volume":"71","author":"Wang","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0169-328X(98)00212-5","article-title":"Mu-opioid receptor knockout mice: role of opioid receptors in morphine mediated immune functions","volume":"61","author":"Roy","year":"1998","journal-title":"Mol Brain Res"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"6326","DOI":"10.1073\/pnas.95.11.6326","article-title":"Abolition of morphine immunosuppression in mice lacking the mu-opioid receptor gene","volume":"95","author":"Gaveriaux Ruff","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0022-3565(25)12317-3","article-title":"Assessment of the involvement of central nervous system and peripheral opioid receptors in the immunomodulatory effects of acute morphine treatment in rats","volume":"276","author":"Fecho","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0031-6997(24)01470-4","article-title":"The sympathetic nerve: an integrative interface between two supersystems: the brain and the immune system","volume":"52","author":"Elenkov","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/00000539-200006000-00028","article-title":"Effects of tramadol and morphine on immune responses and pain after surgery in cancer patients","volume":"90","author":"Sacerdote","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-5728(02)00165-0","article-title":"The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats","volume":"29","author":"Gaspani","year":"2002","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000078444","article-title":"Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats","volume":"11","author":"Shavit","year":"2004","journal-title":"Neuroimmunomodulation"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.bbi.2007.01.001","article-title":"Buprenorphine ameliorates the effect of surgery on hypothalamus pituitary adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment","volume":"21","author":"Franchi","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0162-3109(00)00198-3","article-title":"Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray","volume":"48","author":"Gomez-Flores","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1521-6616(03)00177-3","article-title":"No detrimental effect from chronic exposure to buprenorphine on corticosteroid-binding globulin and corticosensitive immune parameters","volume":"109","author":"D'Elia","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB63|cit63","first-page":"404","article-title":"Non peptide opioids: in vivo effects on the immune system","volume":"105","author":"Williams","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.pain.2004.04.020","article-title":"Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses","volume":"110","author":"Martucci","year":"2004","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s00213-005-2239-x","article-title":"Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers","volume":"179","author":"Neri","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bbi.2007.12.013","article-title":"Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function","volume":"22","author":"Sacerdote","year":"2008","journal-title":"Brain Behav Immun"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00002508-200305000-00004","article-title":"Gonadal hormones and sex differences in pain reactivity","volume":"19","author":"Aloisi","year":"2003","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1210\/en.2004-1142","article-title":"Strategies and methods for research on sex differences in brain and behavior","volume":"146","author":"Becker","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1468-2982.1990.1004183.x","article-title":"Sex steroids and cluster headache: hypotheses","volume":"10","author":"Polleri","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neulet.2003.12.023","article-title":"Testosterone affects formalin-induced responses differently in male and female rats","volume":"361","author":"Aloisi","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pain.2005.02.019","article-title":"Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF)","volume":"115","author":"Aloisi","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0885-3924(94)90166-X","article-title":"Altered sexual function and decreased testosterone in patients receiving intraspinal opioids","volume":"9","author":"Paice","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.yhbeh.2008.02.016","article-title":"Androgens in health and disease: an overview","volume":"53","author":"Jordan","year":"2008","journal-title":"Horm Behav"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.neuroscience.2006.02.044","article-title":"Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats","volume":"140","author":"Ceccarelli","year":"2006","journal-title":"Neuroscience"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0885-3924(02)00539-0","article-title":"Driving ability under long-term treatment with transdermal fentanyl","volume":"25","author":"Sabatowski","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1399-6576.2006.01027.x","article-title":"Assessing cognition and psychomotor function under long-term treatment with controlled release oxycodone in non-cancer pain patients","volume":"50","author":"Gaertner","year":"2006","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1213\/01.ane.0000281078.65585.1e","article-title":"Assessing cognitive and psychomotor performance under long-term treatment with transdermal buprenorphine in chronic noncancer pain patients","volume":"105","author":"Dagtekin","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1054\/bjoc.2001.1680","article-title":"for the Expert Working Group of the Research Network of the European Association for Palliative Care. Morphine and alternative opioids in cancer pain: the EAPC recommendations","volume":"84","author":"Hanks","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/AJP.0b013e3181673b65","article-title":"Comparable analgesic efficacy of transdermal buprenorphine in patients over and under 65 years of age","volume":"24","author":"Likar","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.clinthera.2007.08.001","article-title":"Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison","volume":"29","author":"Likar","year":"2007","journal-title":"Clin Ther"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ctrv.2006.03.001","article-title":"Opioid switching: a systematic and critical review","volume":"32","author":"Mercadante","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(99)01310-0","article-title":"Management of cancer pain","volume":"353","author":"Portenoy","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","article-title":"Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing","volume":"22","author":"Pereira","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1742-1241.2007.01531.x","article-title":"Challenging the equipotency calculation for transdermal buprenorphine: four case studies","volume":"62","author":"Likar","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.clinthera.2005.02.012","article-title":"Equipotent doses of transdermal fentanyl and buprenorphine in patients with cancer and non-cancer pain: results of a retrospective cohort study","volume":"27","author":"Sittl","year":"2005","journal-title":"Clin Ther"},{"issue":"V","key":"10.1111\/j.1533-2500.2010.00378.x-BIB87|cit87","first-page":"22","article-title":"Transdermal buprenorphine for the management of nociceptive chronic pain","volume":"11","author":"Camba","year":"2004","journal-title":"Rev Soc Esp Dolor"},{"issue":"V","key":"10.1111\/j.1533-2500.2010.00378.x-BIB88|cit88","first-page":"11","article-title":"Transdermal buprenorphine in the management of neuropathic pain","volume":"11","author":"Rodriguez-Lopez","year":"2004","journal-title":"Rev Soc Esp Dolor"},{"issue":"V","key":"10.1111\/j.1533-2500.2010.00378.x-BIB89|cit89","first-page":"41","article-title":"Assessment of buprenorphine transdermal patch in patients with cancer pain","volume":"11","author":"Muriel","year":"2004","journal-title":"Rev Soc Esp Dolor"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB90|cit90","first-page":"14","article-title":"Efficacy and safety of buprenorphine TDS in conjunction with oral tramadol or morphine as rescue medication in the treatment of 390 patients with chronic pain: a summary of two retrospective Spanish multicenter studies","volume":"6","author":"De Barutell","year":"2007","journal-title":"J Appl Ther Res"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0736-4679(01)00355-9","article-title":"Relief by naloxone of morphine-induced spasm of the sphincter of Oddi in a post-cholecystectomy patient","volume":"21","author":"Butler","year":"2001","journal-title":"J Emerg Med"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.27.5.567","article-title":"Effect of modern analgesic drugs (tramadol, pentazocine and buprenorphine) on the bile duct sphincter in man","volume":"27","author":"Staritz","year":"1986","journal-title":"Gut"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00609196","article-title":"Effects of buprenorphine on motor activity of the sphincter of Oddi in man","volume":"36","author":"Cuer","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB94|cit94","first-page":"117","article-title":"Transdermal buprenorphine in cancer pain: a renewed therapeutic opportunity","volume":"2","author":"Mercadante","year":"2006","journal-title":"Support Palliat Cancer Care"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpainsymman.2006.01.013","article-title":"Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine","volume":"32","author":"Mercadante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00520-006-0169-8","article-title":"Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients","volume":"15","author":"Mercadante","year":"2007","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jpainsymman.2007.01.006","article-title":"Switching from transdermal drugs: an observational \u201cN of 1\u201d study of fentanyl and buprenorphine","volume":"34","author":"Mercadante","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jpainsymman.2003.09.006","article-title":"Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose","volume":"27","author":"Mercadante","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00520-008-0546-6","article-title":"Equipotent doses to switch from high doses of opioids to transdermal buprenorphine","volume":"17","author":"Mercadante","year":"2009","journal-title":"Support Care Cancer"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"An evidence-based algorithm for the treatment of neuropathic pain","volume":"118","author":"Finnerup","year":"2005","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"Eur J Neurol"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2007.08.033","article-title":"Pharmacologic management of neuropathic pain: evidence-based recommendations","volume":"132","author":"Dworkin","year":"2007","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1213\/01.ANE.0000145066.06538.20","article-title":"Transdermal buprenorphine for treating nociceptive and neuropathic pain: four case studies","volume":"100","author":"Likar","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB105|cit105","unstructured":"Fogliardi A Transdermal buprenorphine (buprenorphine TDS) in post-herpetic neuropathy 2005 1"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0885-3924(92)90116-Y","article-title":"Long term oral opioid therapy in patients with chronic non-malignant pain","volume":"7","author":"Zenz","year":"1992","journal-title":"J Pain Symptom Manage"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3959(97)00172-3","article-title":"Dose-response relationship of opioids in nociceptive and neuropathic postoperative pain","volume":"74","author":"Benedetti","year":"1998","journal-title":"Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.otohns.2006.02.027","article-title":"Morphine\/ondansetron PCA for postoperative pain, nausea, and vomiting after skull base surgery","volume":"135","author":"Jellish","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejpain.2005.02.002","article-title":"Interaction of \u03bc-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice","volume":"9","author":"K\u00f6gel","year":"2005","journal-title":"Eur J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB110|cit110","doi-asserted-by":"crossref","unstructured":"Troester A Sittl R Koppert W Quantification of analgesic and antihyperalgesic effects of buprenorphine and fentanyl in healthy volunteers 2005","DOI":"10.1097\/00003643-200505001-00673"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1163\/156856900750229889","article-title":"Pain relief after simultaneous administration of intravenous buprenorphine and intrathecal morphine in terminally ill patients: a report of two cases","volume":"12","author":"Beltrutti","year":"2000","journal-title":"Pain Clin"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0952-8180(02)00397-5","article-title":"Late antinociception and lower untoward effects of concomitant intrathecal morphine and intravenous buprenorphine in humans","volume":"14","author":"Beltrutti","year":"2002","journal-title":"J Clin Anesth"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clinthera.2009.03.018","article-title":"Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a four arm randomized double blind trial in adults undergoing abdominal surgery","volume":"31","author":"Oifa","year":"2009","journal-title":"Clin Ther"},{"issue":"2","key":"10.1111\/j.1533-2500.2010.00378.x-BIB114|cit114","first-page":"14 Abstr 653","article-title":"Effectiveness and safety of buprenorphine transdermal system (BTDS) compared with hydrocodone\/acetaminophen in the treatment of patients with low back pain","volume":"3","author":"Spyker","year":"2002","journal-title":"J Pain"},{"key":"10.1111\/j.1533-2500.2010.00378.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jpainsymman.2003.10.006","article-title":"Use of strong opioids in advanced cancer pain: a randomized trial","volume":"27","author":"Marinangeli","year":"2004","journal-title":"J Pain Symptom Manage"}],"container-title":["Pain Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1533-2500.2010.00378.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:28:12Z","timestamp":1740072492000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1533-2500.2010.00378.x"}},"subtitle":["Current Knowledge of Buprenorphine"],"short-title":[],"issued":{"date-parts":[[2010,8,30]]},"references-count":115,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1533-2500.2010.00378.x","relation":{},"ISSN":["1530-7085"],"issn-type":[{"value":"1530-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8,30]]}}}